← FDA Drug Approvals (Drugs@FDA)

TOLVAPTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2023-06-21

Drug application

FDA Application #

ANDA216949

Application type

Abbreviated New Drug Application (Generic)

Brand name

TOLVAPTAN

Generic name

TOLVAPTAN

Active ingredients

TOLVAPTAN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MSN

Manufacturer

Novadoz Pharmaceuticals LLC

First approval

2023-06-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown